# OnCo record sarcoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/sarcoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "sarcoma" ;
  schema:name "Sarcomas (soft tissue, bone, GIST)"@en ;
  schema:alternateName "Soft Tissue Sarcoma"@en ;
  schema:description "Sarcomas are dozens of rare cancers of bone and connective tissue. GIST was the first solid tumour cured-in-practice by a targeted pill; synovial sarcoma got the first TCR-T therapy."@en ;
  schema:url <https://onco.cc/cancers/sarcoma/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Sarcoma> ;
  owl:sameAs <http://www.wikidata.org/entity/Q223911> ;
  schema:citation <https://en.wikipedia.org/wiki/Sarcoma> ;
  onco:tag "rare", "spike" ;
  onco:related <https://onco.cc/pairings/ctdna-genotype-gist-tki/>, <https://onco.cc/pairings/doxorubicin-cardio-caution/>, <https://onco.cc/cancers/chordoma/>, <https://onco.cc/cancers/desmoid-tumour/>, <https://onco.cc/cancers/tenosynovial-giant-cell-tumour/>, <https://onco.cc/cancers/vascular-tumours/>, <https://onco.cc/cancers/uterine-sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/tcr-t/>, <https://onco.cc/technologies/carbon-ion/>, <https://onco.cc/technologies/hyperthermia/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/limb-salvage-surgery/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/cardio-oncology/> ;
  onco:targets <https://onco.cc/targets/kit/>, <https://onco.cc/targets/mage-a4/>, <https://onco.cc/targets/ntrk/>, <https://onco.cc/targets/ezh2/>, <https://onco.cc/targets/cdk4-6/>, <https://onco.cc/targets/fap/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/sirolimus-albumin-bound/>, <https://onco.cc/drugs/tasonermin/> ;
  onco:companies <https://onco.cc/companies/philogen-s-p-a/>, <https://onco.cc/companies/haihe-biopharma/>, <https://onco.cc/companies/epicentrx/>, <https://onco.cc/companies/qbiotics/>, <https://onco.cc/companies/ranok-therapeutics-hangzhou/>, <https://onco.cc/companies/deciphera/>, <https://onco.cc/companies/springworks/>, <https://onco.cc/companies/us-worldmeds/>, <https://onco.cc/companies/novartis/>, <https://onco.cc/companies/johnson-johnson/>, <https://onco.cc/companies/sanofi/>, <https://onco.cc/companies/adaptimmune/>, <https://onco.cc/companies/immatics/>, <https://onco.cc/companies/childrens-oncology-group/>, <https://onco.cc/companies/curie-nki-eortc/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/>, <https://onco.cc/institutions/md-anderson/>, <https://onco.cc/institutions/royal-marsden/>, <https://onco.cc/institutions/gustave-roussy/>, <https://onco.cc/institutions/int-milan/> ;
  onco:terms <https://onco.cc/terms/fnclcc-grade/>, <https://onco.cc/terms/sarcoma-histotype-tailoring/>, <https://onco.cc/terms/orr/>, <https://onco.cc/terms/pfs/>, <https://onco.cc/terms/limb-salvage-term/> ;
  onco:trials <https://onco.cc/trials/invincible-3/>, <https://onco.cc/trials/nct07174427/>, <https://onco.cc/trials/nct03016819/>, <https://onco.cc/trials/nct06127407/> ;
  onco:people <https://onco.cc/people/kate-granger/>, <https://onco.cc/people/sid-sijbrandij/> ;
  onco:pipeline <https://onco.cc/drugs/fap-2286/>, <https://onco.cc/technologies/carbon-ion/>, <https://onco.cc/drugs/hs-20093/>, <https://onco.cc/drugs/gotistobart/>, <https://onco.cc/drugs/int230-6/>, <https://onco.cc/drugs/tbi-1301/>, <https://onco.cc/drugs/t3011/>, <https://onco.cc/drugs/letetresgene-autoleucel/>, <https://onco.cc/trials/ignyte-eso/>, <https://onco.cc/trials/insight-gist/>, <https://onco.cc/pairings/ctdna-genotype-gist-tki/>, <https://onco.cc/ideas/idea-tcr-t-beyond-hla-a2/>, <https://onco.cc/ideas/idea-desmoid-intermittent-dosing/>, <https://onco.cc/drugs/vimseltinib/>, <https://onco.cc/drugs/nirogacestat/>, <https://onco.cc/technologies/limb-salvage-surgery/> ;
  onco:standardOfCare <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/hyperthermia/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/drugs/afamitresgene-autoleucel/>, <https://onco.cc/technologies/limb-salvage-surgery/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/terms/fnclcc-grade/>, <https://onco.cc/trials/isg-sts-1001/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/hyperthermia/>, <https://onco.cc/technologies/limb-salvage-surgery/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/trabectedin/>, <https://onco.cc/trials/announce/>, <https://onco.cc/terms/sarcoma-histotype-tailoring/>, <https://onco.cc/drugs/trabectedin/>, <https://onco.cc/drugs/pazopanib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/afamitresgene-autoleucel/>, <https://onco.cc/drugs/letetresgene-autoleucel/>, <https://onco.cc/trials/ignyte-eso/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/trials/ssgxviii/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/drugs/ripretinib/>, <https://onco.cc/trials/invictus/>, <https://onco.cc/trials/insight-gist/>, <https://onco.cc/drugs/avapritinib/>, <https://onco.cc/pairings/ctdna-genotype-gist-tki/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/technologies/limb-salvage-surgery/>, <https://onco.cc/companies/childrens-oncology-group/>, <https://onco.cc/trials/int-0091/>, <https://onco.cc/trials/euro-ewing-2012/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/trials/aews0031/>, <https://onco.cc/drugs/nirogacestat/>, <https://onco.cc/trials/defi/>, <https://onco.cc/technologies/thermal-ablation/>, <https://onco.cc/ideas/idea-desmoid-intermittent-dosing/>, <https://onco.cc/drugs/vimseltinib/>, <https://onco.cc/trials/motion/> .